Atea Pharmaceuticals, Inc. (AVIR) vs Capricor Therapeutics, Inc. (CAPR)
A side-by-side comparison of Atea Pharmaceuticals, Inc. and Capricor Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVIR
Atea Pharmaceuticals, Inc.
$5.07HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
CAPR
Capricor Therapeutics, Inc.
$7.78HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — AVIR vs CAPR
growth of $100 · dividends reinvested · last 6yAVIR -83.1% (-25.6%/yr)CAPR +78.0% (+10.1%/yr)CAPR compounded faster over this window
Log scale — wide-divergence pair
AVIR CAPR
AVIR vs CAPR: by the numbers
- •CAPR is the larger company ($447M vs $406M market cap).
Metrics side by side
Valuation
| Metric | AVIR | CAPR |
|---|---|---|
| P/B ratio | 1.99 | 1.82 |
| EV / EBITDA | N/A | 0.44 |
Profitability
| Metric | AVIR | CAPR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -80.96% | -52.56% |
| ROIC | -89.93% | -40.25% |
Growth (annualized)
| Metric | AVIR | CAPR |
|---|---|---|
| Total return CAGR (5Y) | -34.44% | 15.17% |
Frequently asked
- How have AVIR and CAPR total returns compared?
- Over the past 5 years, AVIR delivered -34.44% and CAPR delivered 15.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.